Colle Capital Partners
VC Fund
New York, United States
Colle Capital Partners is a VC fund in New York focused on Software and Health Care. Colle Capital is an opportunistic, global technology venture fund. We focus on early stage companies that offer products and services in a broad range of verticals, such as telecommunications, computing, compliance, healthcare, wireless, financial services, security, home automation and information technology.
- Total investments:
- 108
- Last investment:
- Lead investor:
- 15%
- Fund size:
- $72M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Colle Capital Partners invests in
Stages Colle Capital Partners invests in
Countries Colle Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.1M–$8M
- Series A
- $2.5M–$21M
- Series B
- $3.7M–$126M
Investment Focus
Industry
- Software 22 (20%)
- Health Care 16 (15%)
- Artificial Intelligence 12 (11%)
- Financial Services 10 (9%)
- SaaS 9 (8%)
Stage
- Seed 38 (35%)
- Series A 29 (27%)
- Series B 9 (8%)
- Venture - Series Unknown 7 (6%)
- Pre-Seed 5 (5%)
Country
- United States 63 (58%)
- United Kingdom 4 (4%)
- Kenya 3 (3%)
- United Arab Emirates 2 (2%)
- India 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Doug Benowitz
Principal
|
Principal | Total investments: 1 | Find email | |
Kevin Lynch
Fund Administrator
|
Fund Administrator | Total investments: 0 | Find email | |
Victoria Grace
Founder
|
Founder | Total investments: 24 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to goldstandard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring. | $6M / Venture - Series Unknown / Oct 13, 2026 | ||
| Itera provides digital consulting, AI, cloud, software development and technology services for businesses across industries. | $12M / Seed / May 27, 2026 | ||
| Dandelion Health AI develops a clinical data and artificial intelligence platform that enables life sciences companies and researchers to analyze real-world patient data and accelerate drug development and clinical research. The company provides a precision medicine platform that aggregates multimodal healthcare data, including clinical notes,medical images, and physiological waveforms, into a unified dataset representing patient journeys over time. Its platform applies validated AI models to transform large volumes of unstructured clinical data into structured, research-ready datasets, allowing researchers to uncover insights into disease progression, treatment effectiveness, and patient outcomes. This capability enables more comprehensive analysis compared to traditional datasets that rely primarily on structured records such as claims or diagnostic codes. | $14M / Series A / May 05, 2026 | ||
| Neuron Factory is an AI technology company specializing in the development of advanced AI coworker platforms designed for complex enterprise environments, with an initial focus on the construction industry. The company’s platform leverages a proprietary enterprise task graph, enabling AI agents to intelligently coordinate, delegate tasks, andfacilitate real-time decision-making across large organizations. | Seed / Mar 31, 2026 | ||
| Flexnode offers a novel and sustainable data computing, storage, and networking lifecycle solution. | Series A / Jan 28, 2026 | ||
| Cohesive is the Business AI Operating System designed to transform fragmented workflows into streamlined, actionable processes. | $4.5M / Seed / Dec 23, 2025 | ||
| Farmers Business Network is an independent and unbiased, farmer-to-farmer agronomic information network. The Network's mission is to improve the livelihood of farmers by making data useful and accessible. Farmers Business Network (FBN) utilizes data science and machine learning to provide members with unbiased and unprecedented insightsabout each of their fields, powered by billions of data points from our network. IT provides farmers with product performance, benchmarking and predictive analytics based on real-world performance data | $50M / Jul 28, 2025 | ||
| Neuron Factory is an AI technology company specializing in the development of advanced AI coworker platforms designed for complex enterprise environments, with an initial focus on the construction industry. The company’s platform leverages a proprietary enterprise task graph, enabling AI agents to intelligently coordinate, delegate tasks, andfacilitate real-time decision-making across large organizations. | $6M / Seed / May 27, 2025 | ||
| PIKL is a HR tech company that uses AI to provide staffing companies with end-to-end automation and a flawless experience for their teams. | $7.2M / Venture - Series Unknown / Mar 25, 2025 | ||
| Licensed To Glow provides membership-based access to salon, spa, massage, facial, wellness, and self-care services through a digital booking platform. The company connects users with beauty and wellness providers and offers tools for scheduling appointments, managing memberships, and accessing personal care services across multiple categories. | $1.7M / Pre-Seed / Jan 01, 2025 | ||
| See all 108 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Colle Capital Partners invest in?
Colle Capital Partners invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 108 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Colle Capital Partners invest in?
Colle Capital Partners typically joins rounds of $1.1M–$8M at Seed, $2.5M–$21M at Series A and $3.7M–$126M at Series B. These are whole funding-round sizes, not Colle Capital Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Colle Capital Partners took part in.
How do I contact Colle Capital Partners?
Public channels for Colle Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Colle Capital Partners?
The team at Colle Capital Partners includes Doug Benowitz (Principal), Kevin Lynch (Fund Administrator) and Victoria Grace (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
